Gapping down
In reaction to earnings/guidance:
- HIMX -2.1% (guidance)
Other news:
- ACAD -32.1% (provides update from FDA Advisory Committee for NUPLAZID; concluded pimavanserin is ineffective for the treatment of hallucinations and delusions in the ADP population)
- RADA -3% (RADA Electronic Industries & Leonardo DRS agree to all-stock merger combining top defense technology companies into leader in advanced sensing and force protection)
- FXLV -1.1% (files for 18857319 share common stock offering by selling shareholders)
Analyst comments:
- HYLN -3% (downgraded to Underweight from Neutral at JP Morgan)
- SPWR -2.7% (downgraded to Sell from Neutral at Goldman)
- IP -2.1% (downgraded to Neutral from Buy at Citigroup)
- PNTG -1.3% (downgraded to Equal-Weight from Overweight at Stephens)
- NOVA -0.8% (downgraded to Neutral from Buy at Goldman)
- ADBE -0.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)